ASR Vermogensbeheer N.V. Decreases Position in Amrize Ltd $AMRZ

Key Points

• ASR Vermogensbeheer reduced its Amrize stake by 60.5% in the fourth quarter, leaving it with 28,686 shares valued at about $1.58 million.
• Amrize insiders have been buying shares, including Jaime Hill and CFO Ian A. Johnston, with insiders purchasing 77,836 shares worth about $4.5 million over the last 90 days.
• The company reported Q1 earnings below estimates but beat-year-over-year revenue growth, while analysts still hold a generally positive view with an average Moderate Buy rating and a target price of $64.50.

ASR Vermogensbeheer N.V. cut its stake in shares of Amrize Ltd (NYSE:AMRZ - Free Report) by 60.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,686 shares of the company's stock after selling 43,891 shares during the period. ASR Vermogensbeheer N.V.'s holdings in Amrize were worth $1,578,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also made changes to their positions in the company. State of Wyoming purchased a new stake in shares of Amrize in the third quarter valued at $32,000. Laurel Wealth Advisors LLC purchased a new stake in shares of Amrize in the fourth quarter valued at $34,000. US Bancorp DE purchased a new stake in shares of Amrize in the third quarter valued at $38,000. Costello Asset Management INC purchased a new stake in shares of Amrize in the third quarter valued at $44,000. Finally, Global Retirement Partners LLC purchased a new stake in shares of Amrize in the third quarter valued at $48,000.

Insider Buying and Selling at Amrize

In other Amrize news, insider Jaime Hill bought 3,184 shares of the business's stock in a transaction on Monday, March 9th. The shares were acquired at an average price of $56.34 per share, with a total value of $179,386.56. Following the transaction, the insider owned 26,000 shares of the company's stock, valued at approximately $1,464,840. This trade represents a 13.96% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Ian A. Johnston bought 4,250 shares of the business's stock in a transaction on Tuesday, March 10th. The shares were acquired at an average cost of $58.94 per share, for a total transaction of $250,495.00. Following the transaction, the chief financial officer directly owned 25,110 shares in the company, valued at approximately $1,479,983.40. This trade represents a 20.37% increase in their position. The SEC filing for this purchase provides additional information. In the last ninety days, insiders have bought 77,836 shares of company stock worth $4,511,449. 0.54% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on AMRZ shares. JPMorgan Chase & Co. raised their price target on Amrize from $60.00 to $70.00 and gave the stock an "overweight" rating in a research note on Thursday, March 5th. Wells Fargo & Company dropped their price objective on Amrize from $66.00 to $65.00 and set an "overweight" rating for the company in a report on Wednesday, April 15th. Weiss Ratings cut Amrize from a "buy (b-)" rating to a "hold (c+)" rating in a report on Monday, May 4th. Truist Financial dropped their price objective on Amrize from $75.00 to $65.00 and set a "buy" rating for the company in a report on Friday, May 1st. Finally, Morgan Stanley restated an "overweight" rating and set a $65.00 price objective on shares of Amrize in a report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $64.50.

Amrize Trading Down 0.1%

AMRZ opened at $52.85 on Monday. The stock's fifty day moving average is $57.20 and its two-hundred day moving average is $55.08. The company has a market capitalization of $29.23 billion and a P/E ratio of 25.29. Amrize Ltd has a 52 week low of $44.12 and a 52 week high of $65.94. The company has a quick ratio of 0.89, a current ratio of 1.40 and a debt-to-equity ratio of 0.38.

Amrize (NYSE:AMRZ - Get Free Report) last released its quarterly earnings data on Wednesday, April 29th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.02). The firm had revenue of $2.18 billion for the quarter. Amrize had a return on equity of 9.84% and a net margin of 9.70%.The company's quarterly revenue was up 4.7% compared to the same quarter last year. Analysts forecast that Amrize Ltd will post 2.7 earnings per share for the current year.

Amrize Cuts Dividend

The firm also recently announced a dividend, which will be paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th will be given a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, May 12th.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.